Video Experimental Relacionado
Updated: Aug 10, 2026

08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
El oncogén celular p53 puede ser activado por mutagenesis
Nature
|October 6, 1985
Resumen
La proteína supresora de tumores p53 puede inmortalizar las células a través de diferentes mecanismos, con algunos mutantes que impiden una mayor transformación por el ras oncogene. Esto sugiere roles distintos para p53 en la inmortalización celular y la cooperación oncogénica.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Biología celular Biología celular.
- Oncología Oncología.
Sus antecedentes:
- La fosfoproteína p53 es crucial en las respuestas celulares a varios estímulos transformadores como virus, productos químicos y radiación.
- p53 forma complejos con proteínas virales, incluido el antígeno SV40 T grande y el adenovirus E1b.
- Estudios previos vincularon p53 a la proliferación celular y sus construcciones de expresión a la inmortalización celular y la sensibilidad a la transformación de oncogenes ras.
Objetivo del estudio:
- Para investigar las propiedades biológicas de las construcciones de expresión de p53.
- Determinar los mecanismos por los cuales la p53 influye en la inmortalización celular y la vida útil.
- Explorar la relación entre la actividad inmortalizadora de p53 y su cooperación con el ras oncogene.
Principales métodos:
- Utilizó un conjunto de construcciones de expresión de ADN complementario p53 (ADNc).
- Se examinaron los efectos de diferentes construcciones de promotores / potenciadores en la inmortalización mediada por p53 de tipo silvestre.
- Se analizaron los mutantes p53 que producen productos de proteínas estables y su impacto en la vida útil celular y la transformación ras.
Principales resultados:
- Se descubrió que la inmortalización celular por el ADNcp53 de tipo salvaje depende del promotor / potenciador específico utilizado.
- p53 demostró un mecanismo distinto para extender la vida celular a través de reordenamientos de secuencias de codificación que producen proteínas estables.
- Las células inmortalizadas por ciertos mutantes p53 se volvieron resistentes a la posterior transformación oncogénica ras.
Conclusiones:
- La inmortalización celular y la cooperación con el oncogén ras son funciones separadas de p53.
- El contexto promotor / potenciador influye críticamente en el potencial de inmortalización de p53.
- Las formas mutantes de p53 pueden conferir resistencia a la transformación mediada por la raza, destacando distintas actividades biológicas.
Videos de Conceptos Relacionados
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

